ATNM icon

Actinium Pharmaceuticals
ATNM

Overview Fund Trends Analyst Outlook Journalist POV

42 hedge funds and large institutions have $11.5M invested in Actinium Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 10 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

less ownership

Funds ownership: →

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

20% less repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 10

33% less capital invested

Capital invested by funds: $17.1M → $11.5M (-$5.65M)

Holders
42
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$3.01M
Puts
$2.84M
Net Calls
Net Calls Change

Top Buyers

1
+$282K
2
+$90.4K
3
+$84K
4
BCM
Bridgeway Capital Management
Texas
+$58.9K
5
BlackRock
BlackRock
New York
+$54.6K

Top Sellers

1
-$199K
2
-$158K
3
-$145K
4
WANY
Wealthspire Advisors (New York)
New York
-$127K
5
BC
BIT Capital
Germany
-$125K
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$7.81K
27
$6K
28
$6K
29
$5K
30
$5K
31
$4K
32
$2K
33
$1.6K
34
$1K
35
$1K
36
–
37
–
38
–
39
–
40
–
41
–
42
–
43
–
44
–
45
–
1
2